July 14,2006
Chairman Grassley Questions CMS, FDA About Substituted Inhalation Drugs
Please see the printer-friendly version of Chairman Grassley's letter CMS and FDA regarding substituted inhalation drugs.
Next Article Previous Article
Recent News
- Crapo Statement at Hearing on Social Security Disability Benefits
- Crapo Statement at Executive Session to Vote on Treasury Inspector General and Tax Court Judges Nominees
- Crapo Statement at Hearing on Residential Treatment Facilities
- Crapo Statement at Hearing on Trade Preference Programs
- Crapo Statement at Hearing to Consider Nominations for Treasury Inspector General and Tax Court Judges